Axillary lymph node dissection in breast cancer patients after sentinel node biopsy^*

References

• Goldhirsch A, Ingle JN, Gelber RD, et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol. 2009;20:1319–1329.
   PubMed Web of Science ®Google Scholar
• Blichert-Toft M. Axillary surgery in breast cancer management–background, incidence and extent of nodal spread, extent of surgery and accurate axillary staging, surgical procedures. Acta Oncol. 2000;39:269–275.
   PubMed Web of Science ®Google Scholar
• Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer. 1992;28A:1415–1418.
   PubMed Web of Science ®Google Scholar
• Jatoi I, Benson JR, Toi M. De-escalation of axillary surgery in early breast cancer. Lancet Oncol. 2016;17:e430–e441.
   PubMed Web of Science ®Google Scholar
• Donker M, Straver ME, Wesseling J, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg. 2015;261:378–382.
   PubMed Web of Science ®Google Scholar
• Boughey JC, Ballman KV, Hunt KK, et al. Axillary ultrasound after neoadjuvant chemotherapy and Its impact on sentinel lymph node surgery: results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance). JCO. 2015;33:3386–3393.
   PubMedGoogle Scholar
• Rubio IT. Sentinel lymph node biopsy after neoadjuvant treatment in breast cancer: Work in progress. Eur J Surg Oncol. 2016;42:326–332.
   PubMed Web of Science ®Google Scholar
• Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. JCO. 2016;34:1072–1078.
   PubMed Web of Science ®Google Scholar
• Diepstraten SC, Sever AR, Buckens CF, et al. Value of preoperative ultrasound-guided axillary lymph node biopsy for preventing completion axillary lymph node dissection in breast cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2014;21:51–59.
   PubMed Web of Science ®Google Scholar
• Tvedskov TF. The evolution of the sentinel node procedure in the treatment of breast cancer. Dan Med J. 2017;64:B5402.
   PubMed Web of Science ®Google Scholar
• Husted MA, Haugaard K, Soerensen J, et al. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group. Breast. 2008;17:138–147.
   PubMed Web of Science ®Google Scholar
• Gartner R, Jensen MB, Nielsen J, et al. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009;302:1985–1992.
   PubMed Web of Science ®Google Scholar
• Mejdahl MK, Andersen KG, Gartner R, et al. Persistent pain and sensory disturbances after treatment for breast cancer: six year nationwide follow-up study. BMJ. 2013;346:f1865.
   PubMed Web of Science ®Google Scholar
• Giuliano AE, Ballman K, McCall L, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial. Ann Surg. 2016;264:413–420.
   PubMed Web of Science ®Google Scholar
• Moller S, Jensen MB, Ejlertsen B. The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol. 2008;47:506–524.
   PubMed Web of Science ®Google Scholar
• Damgaard OE, Jensen MB, Kroman N, et al. Quantifying the number of lymph nodes identified in one-stage versus two-stage axillary dissection in breast cancer. Breast. 2013;22:44–46.
   PubMed Web of Science ®Google Scholar
• Degnim AC, Griffith KA, Sabel MS, et al. Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer. 2003;98:2307–2315.
   PubMed Web of Science ®Google Scholar
• de BJ, Frisell J, Andersson Y, et al. Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial. BMC Cancer. 2017;17:379.
   PubMed Web of Science ®Google Scholar
• Canavese G, Bruzzi P, Catturich A, et al. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes. Eur J Surg Oncol. 2014;40:835–842.
   PubMed Web of Science ®Google Scholar
• Verheuvel NC, Ooms HW, Tjan-Heijnen VC, et al. Predictors for extensive nodal involvement in breast cancer patients with axillary lymph node metastases. Breast. 2016;27:175–181.
   PubMed Web of Science ®Google Scholar
• Yun SJ, Sohn YM, Seo M. Risk stratification for axillary lymph node metastases in breast cancer patients: what clinicopathological and radiological factors of primary breast cancer can predict preoperatively axillary lymph node metastases?. Ultrasound Q. 2017;33:15–22.
   PubMed Web of Science ®Google Scholar
• Meretoja TJ, Audisio RA, Heikkila PS, et al. International multicenter tool to predict the risk of four or more tumor-positive axillary lymph nodes in breast cancer patients with sentinel node macrometastases. Breast Cancer Res Treat. 2013;138:817–827.
   PubMed Web of Science ®Google Scholar